HOLX
Hologic, Inc.
Price Chart
No historical data available
Latest Quote
$76.01
Current Price| Open | $76.01 |
| Day High | $76.04 |
| Day Low | $76.00 |
| Volume | 101,956,189 |
Stock Information
| Shares Outstanding | 223.24M |
| Total Debt | $2.52B |
| Cash Equivalents | $2.37B |
| Revenue | $4.13B |
| Net Income | $543.80M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $16.97B |
| P/E Ratio | 31.54 |
| EPS (TTM) | $2.41 |
| Exchange | NMS |
Recent Price History
No history data available. Data will be fetched automatically.
About Hologic, Inc.
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analysis software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology systems; and breast conserving surgery products. In addition, the company provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system. The company sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
đ° Latest News
TD Cowen Cuts TPG PT Amid Q1 Preview for Asset Managers
Insider Monkey âĸ 2026-04-15T05:21:56Z
Software sting: Tech share of direct lending deals drops in Q1 â US Private Credit Monitor
Pitchbook âĸ 2026-04-14T15:04:10ZHologic hires former Baxter leader JosÊ Almeida as CEO
MedTech Dive âĸ 2026-04-08T10:14:00Z
Casey's General Stores Stock Has Been On a Tear. Now It's Joining The S&P 500
Investopedia âĸ 2026-04-07T16:31:42Z
Top Midday Stories: Stocks Fall as US-Iran Ceasefire Hopes Fade; Health Insurance Stocks Rise After Big Medicare Advantage Payment Rate Bump
MT Newswires âĸ 2026-04-07T16:05:02ZA Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocksâ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack
StockStory âĸ 2026-04-07T12:29:50Z
Casey's General Stores To Join S&P 500; DigitalOcean, Broadstone Net Lease Move Up In Index Reshuffle
MT Newswires âĸ 2026-04-07T10:15:06ZNanox Starts 2 Collaborations to Deploy Nanox.ARC in U.S.
Exec Edge âĸ 2026-04-06T23:01:44Z
Caseyâs General Stores Joining S&P 500 This Week
Barrons.com âĸ 2026-04-06T22:29:00Z
Hologic CEO Steve MacMillan to retire after go-private deal
MedTech Dive âĸ 2026-04-06T10:49:44Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,697,200,000 | $1,522,700,000 | $1,663,600,000 | $1,480,500,000 |
| Cost Of Revenue | $1,982,600,000 | $1,802,500,000 | $1,958,900,000 | $1,865,400,000 |
| Total Revenue | $4,100,500,000 | $4,030,300,000 | $4,030,400,000 | $4,862,800,000 |
| Operating Revenue | $4,100,500,000 | $4,030,300,000 | $4,030,400,000 | $4,862,800,000 |
| Expenses | ||||
| Interest Expense | $117,100,000 | $122,100,000 | $111,100,000 | $95,100,000 |
| Total Expenses | $3,315,100,000 | $3,099,300,000 | $3,268,900,000 | $3,232,000,000 |
| Other Income Expense | $-61,500,000 | $-52,500,000 | $-94,800,000 | $39,600,000 |
| Other Non Operating Income Expenses | $9,600,000 | $-4,100,000 | $-1,700,000 | $30,900,000 |
| Net Non Operating Interest Income Expense | $-42,700,000 | $-13,400,000 | $9,400,000 | $-82,200,000 |
| Interest Expense Non Operating | $117,100,000 | $122,100,000 | $111,100,000 | $95,100,000 |
| Operating Expense | $1,332,500,000 | $1,296,800,000 | $1,310,000,000 | $1,366,600,000 |
| Selling And Marketing Expense | $620,600,000 | $585,400,000 | $595,200,000 | $630,300,000 |
| General And Administrative Expense | $449,300,000 | $409,400,000 | $392,400,000 | $407,700,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $565,700,000 | $789,500,000 | $456,000,000 | $1,302,000,000 |
| Net Interest Income | $-42,700,000 | $-13,400,000 | $9,400,000 | $-82,200,000 |
| Interest Income | $74,400,000 | $108,700,000 | $120,500,000 | $12,900,000 |
| Normalized Income | $624,713,000 | $833,689,200 | $518,749,400 | $1,294,866,000 |
| Net Income From Continuing And Discontinued Operation | $565,700,000 | $789,500,000 | $456,000,000 | $1,302,000,000 |
| Total Operating Income As Reported | $714,300,000 | $882,600,000 | $668,400,000 | $1,640,200,000 |
| Net Income Common Stockholders | $565,700,000 | $789,500,000 | $456,000,000 | $1,302,000,000 |
| Net Income | $565,700,000 | $789,500,000 | $456,000,000 | $1,302,000,000 |
| Net Income Including Noncontrolling Interests | $565,700,000 | $789,500,000 | $456,000,000 | $1,302,000,000 |
| Net Income Continuous Operations | $565,700,000 | $789,500,000 | $456,000,000 | $1,302,000,000 |
| Pretax Income | $681,200,000 | $865,100,000 | $676,100,000 | $1,588,200,000 |
| Special Income Charges | $-71,100,000 | $-48,400,000 | $-93,100,000 | $8,700,000 |
| Interest Income Non Operating | $74,400,000 | $108,700,000 | $120,500,000 | $12,900,000 |
| Operating Income | $785,400,000 | $931,000,000 | $761,500,000 | $1,630,800,000 |
| Depreciation Amortization Depletion Income Statement | $14,400,000 | $29,200,000 | $28,100,000 | $45,200,000 |
| Depreciation And Amortization In Income Statement | $14,400,000 | $29,200,000 | $28,100,000 | $45,200,000 |
| Amortization Of Intangibles Income Statement | $14,400,000 | $29,200,000 | $28,100,000 | $45,200,000 |
| Gross Profit | $2,117,900,000 | $2,227,800,000 | $2,071,500,000 | $2,997,400,000 |
| Per Share | ||||
| Diluted EPS | $2.49 | $3.32 | $1.83 | $5.13 |
| Basic EPS | $2.50 | $3.35 | $1.85 | $5.18 |
| Other | ||||
| Tax Effect Of Unusual Items | $-12,087,000 | $-4,210,800 | $-30,350,600 | $1,566,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,169,200,000 | $1,344,600,000 | $1,203,700,000 | $2,104,700,000 |
| Total Unusual Items | $-71,100,000 | $-48,400,000 | $-93,100,000 | $8,700,000 |
| Total Unusual Items Excluding Goodwill | $-71,100,000 | $-48,400,000 | $-93,100,000 | $8,700,000 |
| Reconciled Depreciation | $299,800,000 | $309,000,000 | $323,400,000 | $430,100,000 |
| EBITDA (Bullshit earnings) | $1,098,100,000 | $1,296,200,000 | $1,110,600,000 | $2,113,400,000 |
| EBIT | $798,300,000 | $987,200,000 | $787,200,000 | $1,683,300,000 |
| Diluted Average Shares | $227,573,000 | $237,553,000 | $248,831,000 | $253,845,000 |
| Basic Average Shares | $226,156,000 | $235,723,000 | $246,772,000 | $251,527,000 |
| Diluted NI Availto Com Stockholders | $565,700,000 | $789,500,000 | $456,000,000 | $1,302,000,000 |
| Tax Provision | $115,500,000 | $75,600,000 | $220,100,000 | $286,200,000 |
| Gain On Sale Of Ppe | $0 | $0 | $-51,700,000 | $0 |
| Impairment Of Capital Assets | $42,500,000 | $5,600,000 | $44,300,000 | $27,700,000 |
| Restructuring And Mergern Acquisition | $28,600,000 | $42,800,000 | $-2,900,000 | $-37,100,000 |
| Amortization | $14,400,000 | $29,200,000 | $28,100,000 | $45,200,000 |
| Research And Development | $248,200,000 | $272,800,000 | $294,300,000 | $283,400,000 |
| Selling General And Administration | $1,069,900,000 | $994,800,000 | $987,600,000 | $1,038,000,000 |
| Other Gand A | $449,300,000 | $409,400,000 | $392,400,000 | $407,700,000 |
| Minority Interests | - | - | $0 | $0 |
| Other Special Charges | - | - | - | $700,000 |
Fetched: 2026-04-09
Balance Sheet (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $818,200,000 | $842,300,000 | $847,000,000 | $359,100,000 |
| Total Assets | $9,014,900,000 | $9,156,000,000 | $9,139,300,000 | $9,071,200,000 |
| Total Non Current Assets | $5,346,800,000 | $5,332,700,000 | $4,954,800,000 | $5,209,200,000 |
| Other Non Current Assets | $29,100,000 | $27,000,000 | $44,000,000 | $40,300,000 |
| Non Current Deferred Assets | $239,800,000 | $128,800,000 | $56,600,000 | $16,200,000 |
| Non Current Deferred Taxes Assets | $239,800,000 | $128,800,000 | $56,600,000 | $16,200,000 |
| Non Current Accounts Receivable | $37,400,000 | $37,500,000 | $33,000,000 | $30,400,000 |
| Investmentin Financial Assets | $78,500,000 | $150,700,000 | $15,500,000 | $5,500,000 |
| Goodwill And Other Intangible Assets | $4,229,700,000 | $4,287,700,000 | $4,169,900,000 | $4,517,100,000 |
| Other Intangible Assets | $589,100,000 | $844,600,000 | $888,600,000 | $1,280,600,000 |
| Current Assets | $3,668,100,000 | $3,823,300,000 | $4,184,500,000 | $3,862,000,000 |
| Other Current Assets | $152,000,000 | $156,200,000 | $175,300,000 | $232,200,000 |
| Prepaid Assets | $33,200,000 | $53,300,000 | $31,600,000 | $49,000,000 |
| Inventory | $679,400,000 | $679,800,000 | $617,600,000 | $623,700,000 |
| Receivables | $600,800,000 | $600,400,000 | $625,600,000 | $617,600,000 |
| Accounts Receivable | $600,800,000 | $600,400,000 | $625,600,000 | $617,600,000 |
| Allowance For Doubtful Accounts Receivable | $-38,200,000 | $-41,400,000 | $-38,500,000 | $-37,700,000 |
| Gross Accounts Receivable | $639,000,000 | $641,800,000 | $664,100,000 | $655,300,000 |
| Cash Cash Equivalents And Short Term Investments | $2,202,700,000 | $2,333,600,000 | $2,722,500,000 | $2,339,500,000 |
| Cash And Cash Equivalents | $1,959,500,000 | $2,160,200,000 | $2,722,500,000 | $2,339,500,000 |
| Cash Equivalents | $829,800,000 | $723,100,000 | - | - |
| Cash Financial | $1,129,700,000 | $1,437,100,000 | - | - |
| Assets Held For Sale Current | - | $0 | $11,900,000 | $0 |
| Debt | ||||
| Net Debt | $548,400,000 | $374,400,000 | $95,700,000 | $483,900,000 |
| Total Debt | $2,626,800,000 | $2,658,000,000 | $2,904,100,000 | $2,921,600,000 |
| Long Term Debt And Capital Lease Obligation | $2,593,400,000 | $2,593,200,000 | $2,593,600,000 | $2,880,200,000 |
| Long Term Debt | $2,505,000,000 | $2,497,100,000 | $2,531,200,000 | $2,808,400,000 |
| Current Debt And Capital Lease Obligation | $33,400,000 | $64,800,000 | $310,500,000 | $41,400,000 |
| Current Debt | $2,900,000 | $37,500,000 | $287,000,000 | $15,000,000 |
| Other Current Borrowings | $2,900,000 | $37,500,000 | $287,000,000 | $15,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,967,000,000 | $4,026,000,000 | $4,122,400,000 | $4,195,000,000 |
| Total Non Current Liabilities Net Minority Interest | $2,989,800,000 | $2,988,800,000 | $2,915,100,000 | $3,257,300,000 |
| Other Non Current Liabilities | $10,200,000 | $10,600,000 | $13,200,000 | $25,300,000 |
| Non Current Deferred Liabilities | $386,200,000 | $385,000,000 | $308,300,000 | $351,800,000 |
| Non Current Deferred Taxes Liabilities | $373,800,000 | $371,200,000 | $294,500,000 | $342,400,000 |
| Current Liabilities | $977,200,000 | $1,037,200,000 | $1,207,300,000 | $937,700,000 |
| Current Deferred Liabilities | $199,700,000 | $212,900,000 | $199,200,000 | $186,500,000 |
| Payables And Accrued Expenses | $449,900,000 | $470,500,000 | $409,300,000 | $417,600,000 |
| Payables | $266,200,000 | $273,200,000 | $237,500,000 | $241,900,000 |
| Total Tax Payable | $72,800,000 | $69,400,000 | $62,300,000 | $44,200,000 |
| Accounts Payable | $193,400,000 | $203,800,000 | $175,200,000 | $197,700,000 |
| Other Current Liabilities | - | - | $8,200,000 | $175,700,000 |
| Derivative Product Liabilities | - | - | - | $0 |
| Interest Payable | - | - | - | $7,300,000 |
| Equity | ||||
| Common Stock Equity | $5,047,900,000 | $5,130,000,000 | $5,016,900,000 | $4,876,200,000 |
| Total Equity Gross Minority Interest | $5,047,900,000 | $5,130,000,000 | $5,016,900,000 | $4,876,200,000 |
| Stockholders Equity | $5,047,900,000 | $5,130,000,000 | $5,016,900,000 | $4,876,200,000 |
| Gains Losses Not Affecting Retained Earnings | $-100,800,000 | $-111,500,000 | $-147,600,000 | $-238,200,000 |
| Other Equity Adjustments | $-100,800,000 | $-111,500,000 | $-147,600,000 | $-238,200,000 |
| Retained Earnings | $3,411,500,000 | $2,845,800,000 | $2,056,300,000 | $1,600,300,000 |
| Other | ||||
| Treasury Shares Number | $79,874,000 | $69,460,000 | $58,231,000 | $51,401,000 |
| Ordinary Shares Number | $222,564,000 | $231,725,000 | $241,709,000 | $247,132,000 |
| Share Issued | $302,438,000 | $301,185,000 | $299,940,000 | $298,533,000 |
| Tangible Book Value | $818,200,000 | $842,300,000 | $847,000,000 | $359,100,000 |
| Invested Capital | $7,555,800,000 | $7,664,600,000 | $7,835,100,000 | $7,699,600,000 |
| Working Capital | $2,690,900,000 | $2,786,100,000 | $2,977,200,000 | $2,924,300,000 |
| Capital Lease Obligations | $118,900,000 | $123,400,000 | $85,900,000 | $98,200,000 |
| Total Capitalization | $7,552,900,000 | $7,627,100,000 | $7,548,100,000 | $7,684,600,000 |
| Treasury Stock | $4,611,200,000 | $3,851,500,000 | $3,036,000,000 | $2,531,500,000 |
| Additional Paid In Capital | $6,345,400,000 | $6,244,200,000 | $6,141,200,000 | $6,042,600,000 |
| Capital Stock | $3,000,000 | $3,000,000 | $3,000,000 | $3,000,000 |
| Common Stock | $3,000,000 | $3,000,000 | $3,000,000 | $3,000,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $12,400,000 | $13,800,000 | $13,800,000 | $9,400,000 |
| Long Term Capital Lease Obligation | $88,400,000 | $96,100,000 | $62,400,000 | $71,800,000 |
| Current Deferred Revenue | $199,700,000 | $212,900,000 | $199,200,000 | $186,500,000 |
| Current Capital Lease Obligation | $30,500,000 | $27,300,000 | $23,500,000 | $26,400,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $294,200,000 | $289,000,000 | $280,100,000 | $292,200,000 |
| Current Accrued Expenses | $183,700,000 | $197,300,000 | $171,800,000 | $175,700,000 |
| Defined Pension Benefit | $78,600,000 | $71,000,000 | $56,100,000 | $49,200,000 |
| Investments And Advances | $78,500,000 | $150,700,000 | $15,500,000 | $5,500,000 |
| Available For Sale Securities | $78,500,000 | $150,700,000 | $15,500,000 | $5,500,000 |
| Goodwill | $3,640,600,000 | $3,443,100,000 | $3,281,300,000 | $3,236,500,000 |
| Net PPE | $653,700,000 | $630,000,000 | $579,700,000 | $550,500,000 |
| Accumulated Depreciation | $-792,800,000 | $-728,700,000 | $-714,000,000 | $-705,600,000 |
| Gross PPE | $1,446,500,000 | $1,358,700,000 | $1,293,700,000 | $1,256,100,000 |
| Leases | $49,100,000 | $44,000,000 | $44,400,000 | $44,800,000 |
| Other Properties | $1,073,900,000 | $1,002,200,000 | $959,000,000 | $957,700,000 |
| Machinery Furniture Equipment | $26,500,000 | $24,600,000 | $19,200,000 | $16,700,000 |
| Buildings And Improvements | $256,100,000 | $247,100,000 | $230,000,000 | $196,000,000 |
| Land And Improvements | $40,900,000 | $40,800,000 | $41,100,000 | $40,900,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $363,200,000 | $366,400,000 | $312,700,000 | $310,700,000 |
| Work In Process | $68,400,000 | $62,000,000 | $66,300,000 | $60,100,000 |
| Raw Materials | $247,800,000 | $251,400,000 | $238,600,000 | $252,900,000 |
| Other Short Term Investments | $243,200,000 | $173,400,000 | $0 | - |
| Other Investments | - | $96,400,000 | $0 | - |
| Employee Benefits | - | - | - | $6,800,000 |
| Non Current Pension And Other Postretirement Benefit Plans | - | - | - | $6,800,000 |
| Long Term Provisions | - | - | - | $11,400,000 |
| Current Provisions | - | - | - | $12,000,000 |
| Minority Interest | - | - | - | - |
| Line Of Credit | - | - | - | - |
Fetched: 2026-04-09
Cash Flow Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $904,700,000 | $1,145,000,000 | $901,000,000 | $1,998,500,000 |
| Operating Activities | ||||
| Operating Cash Flow | $1,057,100,000 | $1,285,200,000 | $1,051,200,000 | $2,125,700,000 |
| Cash Flow From Continuing Operating Activities | $1,057,100,000 | $1,285,200,000 | $1,051,200,000 | $2,125,700,000 |
| Operating Gains Losses | - | - | $51,700,000 | $700,000 |
| Investing Activities | ||||
| Capital Expenditure | $-152,400,000 | $-140,200,000 | $-150,200,000 | $-127,200,000 |
| Investing Cash Flow | $-482,700,000 | $-781,000,000 | $-152,100,000 | $-206,300,000 |
| Cash Flow From Continuing Investing Activities | $-482,700,000 | $-781,000,000 | $-152,100,000 | $-206,300,000 |
| Net Other Investing Changes | $-2,900,000 | $-2,000,000 | $13,100,000 | $79,500,000 |
| Capital Expenditure Reported | $-58,800,000 | $-72,400,000 | $-91,800,000 | $-70,600,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-752,900,000 | $-835,100,000 | $-474,800,000 | $-542,100,000 |
| Financing Cash Flow | $-777,200,000 | $-1,108,600,000 | $-483,200,000 | $-756,000,000 |
| Cash Flow From Continuing Financing Activities | $-777,200,000 | $-1,108,600,000 | $-483,200,000 | $-756,000,000 |
| Net Other Financing Charges | $-23,300,000 | $-20,000,000 | $-32,400,000 | $-35,100,000 |
| Net Common Stock Issuance | $-752,900,000 | $-835,100,000 | $-474,800,000 | $-542,100,000 |
| Other | ||||
| Repayment Of Debt | $-1,200,800,000 | $-291,300,000 | $-19,000,000 | $-1,703,500,000 |
| Issuance Of Debt | $1,161,000,000 | $0 | $0 | $1,491,200,000 |
| End Cash Position | $1,959,500,000 | $2,160,200,000 | $2,755,700,000 | $2,339,500,000 |
| Beginning Cash Position | $2,160,200,000 | $2,755,700,000 | $2,339,500,000 | $1,170,300,000 |
| Effect Of Exchange Rate Changes | $2,100,000 | $8,900,000 | $300,000 | $5,800,000 |
| Changes In Cash | $-202,800,000 | $-604,400,000 | $415,900,000 | $1,163,400,000 |
| Proceeds From Stock Option Exercised | $38,800,000 | $37,800,000 | $43,000,000 | $33,500,000 |
| Common Stock Payments | $-752,900,000 | $-835,100,000 | $-474,800,000 | $-542,100,000 |
| Net Issuance Payments Of Debt | $-39,800,000 | $-291,300,000 | $-19,000,000 | $-212,300,000 |
| Net Long Term Debt Issuance | $-39,800,000 | $-291,300,000 | $-19,000,000 | $36,200,000 |
| Long Term Debt Payments | $-1,200,800,000 | $-291,300,000 | $-19,000,000 | $-1,455,000,000 |
| Long Term Debt Issuance | $1,161,000,000 | $0 | $0 | $1,491,200,000 |
| Net Investment Purchase And Sale | $-5,900,000 | $-310,200,000 | $-10,000,000 | $0 |
| Sale Of Investment | $176,000,000 | $0 | $0 | - |
| Purchase Of Investment | $-181,900,000 | $-310,200,000 | $-10,000,000 | $0 |
| Net Business Purchase And Sale | $-321,500,000 | $-328,600,000 | $-5,000,000 | $-158,600,000 |
| Purchase Of Business | $-321,500,000 | $-328,600,000 | $-5,000,000 | $-158,600,000 |
| Net Intangibles Purchase And Sale | $-15,400,000 | $-10,000,000 | $0 | $0 |
| Purchase Of Intangibles | $-15,400,000 | $-10,000,000 | $0 | $0 |
| Net PPE Purchase And Sale | $-78,200,000 | $-57,800,000 | $-58,400,000 | $-56,600,000 |
| Purchase Of PPE | $-78,200,000 | $-57,800,000 | $-58,400,000 | $-56,600,000 |
| Change In Working Capital | $-20,400,000 | $84,100,000 | $11,800,000 | $454,200,000 |
| Change In Other Working Capital | $-15,300,000 | $9,300,000 | $14,400,000 | $-12,300,000 |
| Change In Payables And Accrued Expense | $-43,600,000 | $95,600,000 | $-37,200,000 | $-30,200,000 |
| Change In Accrued Expense | $-32,300,000 | $73,400,000 | $-14,200,000 | $-15,800,000 |
| Change In Payable | $-11,300,000 | $22,200,000 | $-23,000,000 | $-14,400,000 |
| Change In Account Payable | $-11,300,000 | $22,200,000 | $-23,000,000 | $-14,400,000 |
| Change In Prepaid Assets | $32,000,000 | $-14,400,000 | $41,000,000 | $361,000,000 |
| Change In Inventory | $-1,300,000 | $-47,400,000 | $-4,900,000 | $-136,600,000 |
| Change In Receivables | $7,800,000 | $41,000,000 | $-1,500,000 | $272,300,000 |
| Changes In Account Receivables | $7,800,000 | $41,000,000 | $-1,500,000 | $272,300,000 |
| Other Non Cash Items | $43,400,000 | $47,600,000 | $14,000,000 | $-6,900,000 |
| Stock Based Compensation | $84,300,000 | $82,300,000 | $79,600,000 | $66,700,000 |
| Asset Impairment Charge | $225,900,000 | $44,800,000 | $223,800,000 | $45,100,000 |
| Deferred Tax | $-141,600,000 | $-72,100,000 | $-109,100,000 | $-166,200,000 |
| Deferred Income Tax | $-141,600,000 | $-72,100,000 | $-109,100,000 | $-166,200,000 |
| Depreciation Amortization Depletion | $299,800,000 | $309,000,000 | $323,400,000 | $430,100,000 |
| Depreciation And Amortization | $299,800,000 | $309,000,000 | $323,400,000 | $430,100,000 |
| Amortization Cash Flow | $190,900,000 | $209,700,000 | $233,800,000 | $340,900,000 |
| Amortization Of Intangibles | $190,900,000 | $209,700,000 | $233,800,000 | $340,900,000 |
| Depreciation | $108,900,000 | $99,300,000 | $89,600,000 | $89,200,000 |
| Net Income From Continuing Operations | $565,700,000 | $789,500,000 | $456,000,000 | $1,302,000,000 |
| Interest Paid Supplemental Data | - | $117,100,000 | $105,400,000 | $99,700,000 |
| Income Tax Paid Supplemental Data | - | $137,900,000 | $296,100,000 | $36,200,000 |
| Net Short Term Debt Issuance | - | $0 | $0 | $-248,500,000 |
| Short Term Debt Payments | - | $0 | $0 | $-248,500,000 |
| Short Term Debt Issuance | - | - | - | $0 |
| Sale Of Business | - | - | - | $0 |
Fetched: 2026-04-09